The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Treatment outcomes with first-line (1L) nab-Paclitaxel + gemcitabine (AG) and FOLFIRINOX (FFX) in metastatic pancreatic adenocarcinoma (mPAC).
 
Thomas H. Cartwright
Consulting or Advisory Role - Alexion Pharmaceuticals; American Regent; Bayer; BTG; Celgene; Genentech; HERON; Lilly; Seagen; Taiho Pharmaceutical
Speakers' Bureau - Amgen; Astellas Medivation; AstraZeneca; Celgene; Incyte; Janssen Oncology; Taiho Pharmaceutical
Research Funding - Bayer
Expert Testimony - BTG
 
Monika Parisi
Employment - Celgene
Stock and Other Ownership Interests - Celgene
Travel, Accommodations, Expenses - Celgene
 
Janet L. Espirito
Employment - McKesson
Stock and Other Ownership Interests - McKesson
 
Thomas Wilson
Employment - McKesson
Leadership - Trajectory Healthcare
Stock and Other Ownership Interests - Trajectory Healthcare
Patents, Royalties, Other Intellectual Property - Trajectory Healthcare
 
Corey Pelletier
Employment - Celgene
Stock and Other Ownership Interests - Celgene
Travel, Accommodations, Expenses - Celgene
 
Manish Patel
Employment - Celgene
Stock and Other Ownership Interests - Celgene
Travel, Accommodations, Expenses - Celgene
 
Hani M. Babiker
Consulting or Advisory Role - Celgene; Endocyte